01 16BOEHRINGER INGELHEIM
01 1610258637
01 16Blank
01 16Blank
01 162034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 212614
Patent Use Code : U-2731
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 208658
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 212614
Patent Use Code : U-2731
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206073
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
Patent Expiration Date : 2034-04-03
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 10258637
Drug Substance Claim :
Drug Product Claim :
Application Number : 206111
Patent Use Code : U-2290
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-03
